5Hammer A, Bannason J, Lauszus FF. Second trimester rupture in a retroflexed, scarred uterus[J]. J Obstet Co, naecol,2013,33(6) :629- 630.
6Junka A, Bartoszewicz lVi, Smutnicka D, et al. Efficacy of antiseptics containing povidone-iodine, octenidine dihydrocldoride and ethacri- dine lactate against biofilm formed by Pseudomonas aeruginosa and Staphylococcus aureus meas~ with the novel biofilm-oriented anti- septics test[J], lnt Wound J,2014,11(6) :730-734.
7Shaw KA, Topp N J, Shaw JG, et al. Mifepristone-misoprostol dosing interval and effect on induction abortion times: a systematic review [J]. Obstet Gynecol,2013,121 (6) :1335-1347.
8Sun Y, Fang M, Davies H, et al. Mifepristone: a potential clinical agent based on its anti-progesterone and anti-glueocorticoid properties [J]. Gynecol Endocrinol,2014,30(3) :169-173.
9Mei Q, Li X, Liu H, et al. Effectiveness of mifepristone in combina- tion with ethacridine lactate for second trimester pregnancy termination [J]. Eur J Obstet Gynecol Reprod Biol, 2014,178:12-15.
10Zhuang Y, Chen X, Huang L. Mifepristone may shorten the indue- tion-to-abortion time for termination of second-trimester pregnancies by ethacridine lactate[ J ]. Contraception, 2012,85(2) :211-214.
